Literature DB >> 12823493

Post-polio syndrome and total health status in a prospective hospital study.

E Farbu1, T Rekand, N E Gilhus.   

Abstract

New loss of function among patients with previous polio is frequently reported and has several causes. All patients referred to the Department of Neurology, Haukeland University Hospital, Bergen, for 13 months during 2000-2001 with diagnosis late effects of polio were examined prospectively to identify their symptoms and loss of function. Eighty-five patients aged 47-91 years with mean of 61 years were included. The most common complaints were pain (44%), muscular weakness (27%), and fatigue (16%). Muscular weakness occurred in lower limbs in 75%, in respiratory muscles in only 5%. Walking in stairs was impaired in 72% and outdoor walking in 65%. Seventeen patients (19%) reported no loss of function. Post-polio syndrome was diagnosed in 26% of the patients. Polio-related loss of function including cervical and lumbosacral radiculopathies, mononeuropathies and degenerative joint disease were found in an additional 53%. Eleven patients (13%) had distinct non-polio-related disorders that caused new loss of function. The remaining 8% had a stable condition. In conclusion, the majority of polio patients who seek hospital, experience a new loss of function because of polio-related disorders. A careful neurological examination is necessary to identify the correct diagnosis and treatment.

Entities:  

Mesh:

Year:  2003        PMID: 12823493     DOI: 10.1046/j.1468-1331.2003.00613.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  10 in total

Review 1.  Review of secondary health conditions in postpolio syndrome: prevalence and effects of aging.

Authors:  Thomas E McNalley; Kathryn M Yorkston; Mark P Jensen; Anjali R Truitt; Katherine G Schomer; Carolyn Baylor; Ivan R Molton
Journal:  Am J Phys Med Rehabil       Date:  2015-02       Impact factor: 2.159

2.  Analysis of long-standing nociceptive and neuropathic pain in patients with post-polio syndrome.

Authors:  Lars Werhagen; Kristian Borg
Journal:  J Neurol       Date:  2010-03-30       Impact factor: 4.849

3.  Update on current and emerging treatment options for post-polio syndrome.

Authors:  Elisabeth Farbu
Journal:  Ther Clin Risk Manag       Date:  2010-07-21       Impact factor: 2.423

4.  Fatigue, pain and muscle weakness are frequent after Guillain-Barré syndrome and poliomyelitis.

Authors:  Tiina Rekand; Arne Gramstad; Christian A Vedeler
Journal:  J Neurol       Date:  2009-03-06       Impact factor: 4.849

5.  The effects of a home-based arm ergometry exercise programme on physical fitness, fatigue and activity in polio survivors: protocol for a randomised controlled trial.

Authors:  Deirdre Murray; Dara Meldrum; Roisin Moloney; Anna Campion; Frances Horgan; Orla Hardiman
Journal:  BMC Neurol       Date:  2012-12-13       Impact factor: 2.474

6.  Multidimensional fatigue inventory and post-polio syndrome - a Rasch analysis.

Authors:  Anna Dencker; Katharina S Sunnerhagen; Charles Taft; Åsa Lundgren-Nilsson
Journal:  Health Qual Life Outcomes       Date:  2015-02-12       Impact factor: 3.186

7.  The extent of using mobility assistive devices can partly explain fatigue among persons with late effects of polio - a retrospective registry study in Sweden.

Authors:  I Santos Tavares Silva; K S Sunnerhagen; C Willén; I Ottenvall Hammar
Journal:  BMC Neurol       Date:  2016-11-18       Impact factor: 2.474

8.  Role of medical rehabilitation in postpoliomyelitis syndrome. A case report.

Authors:  Gabriela Bombonica Dogaru; Ioana Stănescu
Journal:  Clujul Med       Date:  2013-05-09

9.  Polio Patients in Northern Italy, a 50 Year Follow-up.

Authors:  L Bertolasi; A Danese; S Monaco; M Turri; K Borg; L Werhagen
Journal:  Open Neurol J       Date:  2016-08-31

10.  "The car is my extra legs" - Experiences of outdoor mobility amongst immigrants in Sweden with late effects of polio.

Authors:  Helena Selander; Iolanda Santos Tavares Silva; Felicia Kjellgren; Katharina S Sunnerhagen
Journal:  PLoS One       Date:  2019-10-31       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.